by Clinical Neuropsychologist Online | Wednesday, November 11, 2026 | Dementia
Abstract Alzheimer’s disease (AD), which is characterized by the progressive accumulation of amyloid beta plaques and neurofibrillary tangles (NFTs), metabolic dysfunction, and neuroinflammation, is the most prevalent neurodegenerative disorder. The distinct...
by Clinical Neuropsychologist Online | Monday, November 9, 2026 | Dementia
Abstract INTRODUCTION Dementia prevention research increasingly uses multimodal interventions. Harmonized biomarker practices are essential to enable comparable cross-population analysis with initiatives such as the World-Wide FINGERS (WW-FINGERS) network contributing...
by Clinical Neuropsychologist Online | Monday, November 9, 2026 | Dementia
Abstract INTRODUCTION Circulating plasma metabolites may serve as early indicators of midlife cognitive performance, but whether these associations are also reflected in midlife brain structure or white matter hyperintensity (WMH) burden remains unclear. METHODS In...
by Clinical Neuropsychologist Online | Monday, November 9, 2026 | Dementia
Abstract INTRODUCTION Sleep and dementia are complex phenotypes shaped by genetic and environmental factors, but the genetic contribution of sleep to dementia risk remains unclear. This study examined associations of both phenotypic and genetically predicted sleep...
by Clinical Neuropsychologist Online | Friday, November 6, 2026 | Dementia
Abstract Alzheimer’s disease (AD) is increasingly recognized as a neuroimmune disorder with protective or pathogenic adaptive immunity dependent on the biological context. This review synthesizes evidence from human studies, genetic analyses, mouse models, and...